首页 | 本学科首页   官方微博 | 高级检索  
检索        

经导管肝动脉化疗栓塞预防肝细胞癌术后复发的临床分析
引用本文:卢明柱,徐明,周斌.经导管肝动脉化疗栓塞预防肝细胞癌术后复发的临床分析[J].中国肿瘤临床与康复,2014(12):1471-1473.
作者姓名:卢明柱  徐明  周斌
作者单位:江苏省常州市肿瘤医院肝胆外科,常州213001
摘    要:目的探讨经导管肝动脉化疗栓塞(TACE)预防肝细胞癌根治性切除术后复发的效果。方法回顾性分析2002年6月至2012年6月间收治的44例肝细胞癌患者术后临床病例资料,按术后有无行TACE分为TACE组和单纯手术组,其中单纯手术组20例,术后TACE组24例,随访2年,并对1、2年的复发率进行分析。结果 44例患者均随访2年,TACE组1年和2年的复发率分别为16.7%(4/24)和50.0%(12/24),单纯手术组则分别为40.0%(8/20)和80.0%(16/20),组间差异有统计学意义(P<0.05)。结论肝细胞癌根治性切除术后TACE可以延长肝细胞癌患者术后复发时间。

关 键 词:肝细胞癌  经导管肝动脉化疗栓塞  术后  复发

Clinical analysis of transcatheter arterial chemoembolization on prevention of recurrence after resec- tion of hepatic carcinoma
LU Ming-zhu,XU Ming,ZHOU Bin.Clinical analysis of transcatheter arterial chemoembolization on prevention of recurrence after resec- tion of hepatic carcinoma[J].Chinese Journal of Clinical Oncology and Rehabilitation,2014(12):1471-1473.
Authors:LU Ming-zhu  XU Ming  ZHOU Bin
Institution:( Department of Hepatobiliary Surgery, Changzhou Tumor Hospital, Changzhou 213001, China)
Abstract:Objective To explore the effect of transcatheter arterial chemoembolization (TACE) on prevention of recurrence after resection of hepatocellular carcinoma (HCC). Methods Between June 2002 and June 2012, 44 HCC patients accepting treatment in Changzhou Tumor Hospital were enrolled in the study. And they were randomly devided into TACE group and surgery alone group (TACE group: 24 cases; control group: 20 cases). Results All patients were followed up over 2 years. One and two-year recurrent rate of TACE group were 16.7% (4/24) and 50. 0% (12/24) respectively, the control group were 40.0% (8/20) and 80. 0% (16/20) respectively. The difference was statistically singnificant ( P 〈 0.05). Conclusion TACE can help to delay recurrence after resection of hepatocellular carcinoma. Key words ]
Keywords:Hepatocellular carcinoma  Transcatheter arterial chemoembolization  Postopera- tive  Recurrence
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号